Retinoblastoma at the Campus-University Teaching Hospital in Lome, Togo, from 2014 to 2018

Introduction. - Retinoblastoma is a curable cancer when management is early and prompt.Objective. - To describe the epidemiological, clinical and therapeutic aspects of retinoblas-toma.Materials and methods. - A retrospective study was carried out from January 2014 to Decem-ber 2018 (5 years) at the department of ophthalmology in Campus-University Teaching Hospital, Lome, Togo. It focused on children with retinoblastoma. It included patients with diagno-sis supported by ocular ultrasonography, orbito-cerebral computed tomography scan and/or histopathological examination.Results. - Among the 75 children with ocular cancer, 26 (34.7%) were diagnosed with retino-blastoma. The mean age at presentation was 31 months. The mean time from symptom onset to diagnosis was 15 months. A predominance of proptosis (65.4%), unilateral involvement (76.9%), extraocular tumor extension (65.4%) and endophytic form (96.15%) was found. Of the 32 eyes with retinoblastoma, 7 (21.9%) were enucleated after a mean time from diagnosis to enuclea-tion of 6 months. Two cases of complete remission, 3 cases of tumor recurrence, and 2 cases lost to follow-up were noted.Conclusion. - In our setting, retinoblastoma is a frequent childhood ocular cancer. It is impor-tant to improve the management of retinoblastoma as well as education of the parents. (c) 2021 Elsevier Masson SAS. All rights reserved.